Global Diabetes Care Devices Market 2017-2021

  • ID: 4420470
  • Report
  • Region: Global
  • 99 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton Dickinson
  • DarioHealth
  • Integrity Applications
  • MediWise
  • Nova Biomedical
  • MORE
About Diabetes Care Devices

Diabetes care devices are used to monitor and control the level of blood glucose. It includes SMBG meters, SMBG test strips, insulin pumps, insulin syringes. These are used to administer appropriate amount of insulin to the patient. Diabetes is a lifelong condition, which occurs due to inadequate production of insulin or because the body's cells do not respond properly to insulin, or both. This results in an increase in glucose level in the blood. Individuals suffering from diabetes typically experience polyuria and have high thirst and hunger levels. According to the World Bank Group, as of 2015, the diabetes prevalence rate was 8.52%. Diabetes can be further classified into the following:

The analysts forecast the global diabetes care devices market to grow at a CAGR of 10.72% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global diabetes care devices market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sale of the four diabetes care products, namely SMBG meters, SMBG test strips, insulin pumps, and insulin strips.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Diabetes Care Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott Laboratories
  • Becton Dickinson
  • LifeScan
  • Roche Diagnostics
Other prominent vendors
  • AgaMatrix
  • Animas
  • Beurer
  • Bioptik Technology
  • DarioHealth
  • DexCom
  • GlySens
  • Integrity Applications
  • Medisana
  • MediWise
  • Menarini Diagnostics
  • Nemaura
  • Nova Biomedical
  • Senseonics
  • TaiDoc Technology
Market drivers
  • Friendly reimbursement policies
  • For a full, detailed list, view the full report
Market challenges
  • High cost of devices
  • For a full, detailed list, view the full report
Market trends
  • Rising preference for specialty clinics over hospitals
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton Dickinson
  • DarioHealth
  • Integrity Applications
  • MediWise
  • Nova Biomedical
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market overview
  • End-users for global diabetes care devices
  • Distribution channel for diabetes care devices
  • Market size and forecast
  • Five forces analysis
PART 05: MARKET SEGMENTATION BY PRODUCTS
  • Market overview
  • Global SMBG test strips market
  • Global SMBG meters market
  • Global insulin syringes market
  • Global insulin pumps market
PART 06: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Americas – Market size and forecast
  • EMEA – Market size and forecast
  • APAC – Market size and forecast
  • Market opportunity
PART 07: DECISION FRAMEWORK

PART 08: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 09: MARKET TRENDS
  • Rising preference for specialty clinics over hospitals
  • Increased self-monitoring of diabetes
  • Increased product and process innovation
PART 10: VENDOR LANDSCAPE
  • Competitive scenario
PART 11: KEY VENDOR ANALYSIS
  • Abbott Laboratories
  • Becton Dickinson
  • LifeScan
  • Roche Diagnostics
  • Other prominent vendors
PART 12: APPENDIX0
  • List of abbreviations0
List of Exhibits
Exhibit 01: Tips for using diabetes care devices
Exhibit 02: Snapshot: Global diabetes care devices market 2016-2021
Exhibit 03: Global diabetes care devices market 2016-2021 ($ millions)
Exhibit 04: Stakeholder chart for global diabetes care devices market
Exhibit 05: Five forces analysis
Exhibit 06: Global diabetes care devices market by product type 2016-2021 ($ millions)
Exhibit 07: Global SMBG test strips market 2016-2021 ($ millions)
Exhibit 08: Storage information of blood glucose test strips
Exhibit 09: Global SMBG meters market 2016-2021 ($ millions)
Exhibit 10: Global insulin syringes market 2016-2021 ($ millions)
Exhibit 11: Steps for injecting insulin with a syringe
Exhibit 12: Global insulin pumps market 2016-2021 ($ millions)
Exhibit 13: Advantages and disadvantages of insulin pumps
Exhibit 14: Diabetes care devices market by geography 2016-2021 (% share)
Exhibit 15: Regional comparison
Exhibit 16: Americas – Market size and forecast 2016-2021 ($ millions)
Exhibit 17: Americas – Year-over-year growth
Exhibit 18: Top 3 countries in Americas
Exhibit 19: EMEA – Market size and forecast 2016-2021 ($ millions)
Exhibit 20: EMEA – Year-over-year growth
Exhibit 21: Top 3 countries in EMEA
Exhibit 22: APAC – Market size and forecast 2016-2021 ($ millions)
Exhibit 23: APAC – Year-over-year growth
Exhibit 24: Top 3 countries in APAC
Exhibit 25: Medtronic tie-ups in different countries
Exhibit 26: Competitive parameters in global diabetes care devices market
Exhibit 27: Strategic success factor of companies
Exhibit 28: Abbott Laboratories: Profile
Exhibit 29: Abbott Laboratories: Strength assessment
Exhibit 30: Abbott Laboratories: Strategy assessment
Exhibit 31: Abbott Laboratories: Opportunity assessment
Exhibit 32: Becton Dickinson: Profile
Exhibit 33: Becton Dickinson: Strength assessment
Exhibit 34: Becton Dickinson: Strategy assessment
Exhibit 35: Becton Dickinson: Opportunity assessment
Exhibit 36: LifeScan: Profile
Exhibit 37: LifeScan: Strength assessment
Exhibit 38: LifeScan: Strategy assessment
Exhibit 39: LifeScan: Opportunity assessment
Exhibit 40: Roche Diagnostics: Profile
Exhibit 41: Roche Diagnostics: Strength assessment
Exhibit 42: Roche Diagnostics: Strategy assessment
Exhibit 43: Roche Diagnostics: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton Dickinson
  • DarioHealth
  • Integrity Applications
  • MediWise
  • Nova Biomedical
  • MORE
New Report Released: – Global Diabetes Care Devices Market 2017-2021

The author of the report recognizes the following companies as the key players in the global diabetes care devices market: Abbott Laboratories, Becton Dickinson, LifeScan, and Roche Diagnostics

Other Prominent Vendors in the market are: AgaMatrix, Animas, Beurer, Bioptik Technology, DarioHealth, DexCom, GlySens, Integrity Applications, Medisana, MediWise, Menarini Diagnostics, Nemaura, Nova Biomedical, Senseonics, and TaiDoc Technology.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is Rising preference for specialty clinics over hospitals. In earlier times, the treatment for diabetes was provided in hospitals where an endocrinologist or a dietician guided patient in the management of Type 1 diabetes. Though fruitful results were achieved during the process, there were some issues that made patients look for alternatives. The reasons were long waiting times leading to crowding, limited visiting slots, high consultation fees, and availability of devices stock. As a result, patients had no choice but to revisit hospitals repeatedly to get the check-up done. This looked favorable from the view of hospitals, but not for the patients.”

According to the report, one of the major drivers for this market is Friendly reimbursement policies. Diabetes care devices are mostly expensive and can act as an economic burden on individuals, as these diseases require day-to-day medications. Globally, countries are framing reimbursement policies for diabetes care devices. For example, developed countries such as the US provide coverage for these products under an insurance scheme that is likely to create more demand for diabetes care devices as more people will be able to afford diabetes care devices. Over the past few years, there has been a favorable upgrade in Medicare (the official website of the US Government for medical health related information) reimbursement in the US.

Further, the report states that one of the major factors hindering the growth of this market is High cost of devices. The increasing global diabetic population has led to a rise in the healthcare expenditure on medication as well as insulin delivery devices, especially for Type 1 diabetic population. There are various devices in the market that deliver insulin to patients and monitor blood glucose levels through various routes of administration. The price of these products highly varies, and patients buy products based on the affordability. For instance, the high cost of blood glucose test strips is a major challenge hindering the growth of the global diabetes care devices market. Blood-glucose level monitoring with the use of invasive devices is both painful and expensive process. The pain is due to the lancet pricking the fingertip for blood needed for testing. The expenditure is due to the use of consumable test strips, on which the drop of blood needs to be placed before being inserting into the reader.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott Laboratories
  • Becton Dickinson
  • LifeScan
  • Roche Diagnostics
  • AgaMatrix
  • Animas
  • Beurer
  • Bioptik Technology
  • DarioHealth
  • DexCom
  • GlySens
  • Integrity Applications
  • Medisana
  • MediWise
  • Menarini Diagnostics
  • Nemaura
  • Nova Biomedical
  • Senseonics
  • TaiDoc Technology
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll